Our Nanomedicine & Tumor Microenvironment lab is committed to tackling unmet medical challenges through Bio-Convergence approaches. We design advanced drug delivery platforms by integrating nanotechnology and smart materials. By exploring fundamental mechanisms within tumor biology and merging bioengineering, computational modeling, and nanomedicine, we develop highly selective therapies that enhance treatment outcomes while reducing unintended effects. With innovative 3D-printing methods, we create patient-specific tumoroid-on-a-chip systems, offering a transformative tool for precision oncology and tailored therapeutic testing.